Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...

CHICAGO--(BUSINESS WIRE)--Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under the umbrella of comprehensive technology platform Advyzon, and Syntax Data, a financial ...

Human language is based on syntax, a complex set of rules about how words can be combined. In theory, the emergence of syntactic communication might have been a comparatively straightforward process.